A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading ->
According to an article recently published in the Lancet, some 10% to 25% of the USD $7 trillion spent on healthcare globally every year is lost because of corruption – an amount that exceeds the investments needed to achieve universal healthcare by 2030. To understand how corruption affects healthcare worldwide, the Global Health Centre at […] Continue reading ->
Infant formula companies have “pathologised” normal baby behaviour to promote their products, and there should be “an international, legal treaty” to prevent their marketing,  according to health experts. In addition, political lobbying by milk formula companies to influence public policy should be sharply curtailed.  These are some of the suggestions contained in a three-part series […] Continue reading ->
Hybrid immunity from a combination of being vaccinated and previously infected with COVID-19 offers better protection against hospitalisation and severe infection than immunity simply from a previous infection, according to a new study in The Lancet. People with hybrid immunity were 97.4% less likely to be hospitalised or suffer severe infection at 12 months, whereas those […] Continue reading ->
“Power has been increasingly centralised around the Director-General’s office under Tedros’ leadership. This strategy might be advantageous in a crisis that demands a commander-in-control. But a lack of depth in wider leadership leaves shortcomings in the organisation. Thus states the prestigious medical journal, The Lancet, in an editorial marking the start of WHO Director General Dr Tedros […] Continue reading ->
Two leading researchers who have raised questions about the reliability of Sputnik V’s vaccine efficacy ratings across age groups shared their concerns with Health Policy Watch. One called the results “impossible” and “very concerning”. More than 70 countries have approved the use of Sputnik V, Russia’s COVID-19 vaccine, based on the reported 91.6% efficacy across […] Continue reading ->